Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04602026 · ClinicalTrials.gov registry record · NA

The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gastric Cancer

A NA study of Malignant Solid Neoplasm and Pancreatic Carcinoma, sponsored by Ohio State University Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
66
Enrollment target
1
Study location

NCT04602026: Completed NA study of Malignant Solid Neoplasm and Pancreatic Carcinoma, sponsored by Ohio State University Comprehensive Cancer Center.

NCT04602026 is a NA study of Malignant Solid Neoplasm and Pancreatic Carcinoma that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 66 participants, below the 1,140-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04602026, a NA study of Malignant Solid Neoplasm and Pancreatic Carcinoma, has completed, sponsored by Ohio State University Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
66 participants
Enrollment target
1
Study location

Study Summary

This trial studies how well a prehabilitation program works to improve patient outcomes after surgery compared to the normal standard of care prehabilitation in frail patients undergoing surgery for pancreatic, liver, or gastric cancer. Frailty is defined as the pathophysiology of aging or through the accumulation of physiologic and functional deficits. Prehabilitation programs seek to optimize the medical and physical state of patients prior to undergoing surgery with the goal of improving outcomes following surgery. Despite evidence for its importance in health outcomes for frail patients, prehabilitation programs have not been well studied in cancer surgery populations. This trial may provide researchers with more information on how to improve patient outcomes after cancer surgery through the use of prehabilitation programs.

Primary Outcome

A rapid assessment for frailty using the widely used 5-item fatigue, resistance, ambulation, illness, \& loss of weight (FRAIL) questionnaire will be performed. Patients are identified as frail by scoring 2 or more points on the FRAIL questionnaire. The frailty assessment will be aimed at identifying factors related to the 6 characteristics of frailty: physical performance, gait speed, mobility, nutritional status, mental health and cognition.

Interventions

  • OTHER Questionnaire Administration
  • OTHER Best Practice
  • BEHAVIORAL Exercise Intervention
  • PROCEDURE Physical Therapy

Study Locations (1)

Ohio

  • Ohio State University Comprehensive Cancer Center - Columbus

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2020-09-14
Est. Completion 2024-12-09
Phase NA

What the finished NCT04602026 record still lists

NCT04602026 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 1,140-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (94% lower).

The record links to 4 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 4 interventions - of which Questionnaire Administration is the first listed.

NCT04602026 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT04602026 about?

NCT04602026 is a clinical study titled "The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gastric Cancer". This trial studies how well a prehabilitation program works to improve patient outcomes after surgery compared to the normal standard of care prehabilitation in frail patients undergoing surgery for pancreatic, liver, or gastric cancer. Frailty is defined as the pathophysiology of aging or through t...

What is the current status of trial NCT04602026?

This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2020-09-14. Estimated completion is 2024-12-09.

What conditions does trial NCT04602026 study?

This clinical trial studies the following conditions: Malignant Solid Neoplasm, Pancreatic Carcinoma, Gastric Carcinoma, Adult Liver Carcinoma.

What interventions are being tested in trial NCT04602026?

The interventions under investigation include: Questionnaire Administration (OTHER), Best Practice (OTHER), Exercise Intervention (BEHAVIORAL), Physical Therapy (PROCEDURE).

Who is sponsoring clinical trial NCT04602026?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04602026 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Malignant Solid Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04602026's enrollment target sits among peer trials

66 114th of 176 higher than 63 of 176 other Malignant Solid Neoplasm trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Malignant Solid Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02584244 · 66 participants · Phase 1

    Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

  • NCT03067051 · 66 participants · Phase 1

    Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System

  • NCT03754725 · 66 participants · Phase 1

    Ferritin and Iron Burden in SAH sIRB

  • NCT03875378 · 66 participants · Phase 2

    Transdermal Estrogen in Women With Anorexia Nervosa

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04602026, the US trial registry maintained by the National Library of Medicine. NCT04602026 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.